Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to demonstrate that desoximetasone 0.25% topical spray is
effective for the treatment of patients with moderate to severe plaque psoriasis.